I am also sitting, waiting and looking forward to a good week with gale. Patiently waiting for success on all fronts. The board certainly has taken a "silly" turn with all the blubber and
trash talking knocking down gale, so I just watch from the sidelines.
I hope102 is good and servers the need but expect Galena's Neu Vax vaccine to make a big leap for patients with Her2 bc. Then combine New Vax with Herceptin and WHAM blockbuster.
maybe they did not do anything outside of the box? Maybe gale will recover? Maybe we will experience a
nice rebound? Maybe.........
Sentiment: Strong Buy
more and more discussions on water, running out, used and abused, not enough, drought, wasting precious resources etc. Every few days new fears of lack of future clean fresh potable water etc. etc. etc. Dire predictions of future thirst, wars and more wars over water.
Seems some enterprising company could utilize resources and make a difference.
TEVA Pharmaceuticals is a worldwide pharmaceutical company. They will be responsible for the distribution of the vaccine (neu vax) in Israel and the rest of the world. Galena will receive a royalty on all sales of the drug, once it is approved for use. Phase III trials will start soon in Israel. Currently, there are open trials in the United States and Canada
backlog will be a distant memory when the good old U.S.A hospitals, urology clinics etc. get the ok to utilize this innovative treatment. Many "K"s long and willing to wait.
Sentiment: Strong Buy
think we are off to a good start and will continue according to their latest report....Keep up the good work
and pass those divvy's along month after month after month. I even like the gradual upwardazation(made that word up)of the pps. Same message goes to the sister fund gnt. Just cannot say enough about the $$$$$ they pass out monthly.
I am waiting patiently for the study release later this month.
The Secretary General of the International Federation for Cervical Pathology and Colposcopy (IFCPC), Dr. James Bentley, will present results of a new clinical study of the LuViva® Advanced Cervical Scan at the 15th World Congress for Cervical Pathology and Colposcopy, being held May 26 – 30 in London. The LuViva, a non-invasive device used to detect cervical disease instantly at the point of care, is a product of Guided Therapeutics, Inc Should be interesting reading.